Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Ticker symbol: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and ...
In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...
The Echo® MS+ system unlocks enhanced high-throughput screening capability by bringing acoustic ejection mass spectrometry (AEMS) approaches to the SCIEX ZenoTOF 7600 system. FRAMINGHAM, ...
Biotechnology and pharmaceutical scientists are increasingly relying on high-throughput screening (HTS) methods to discover new leads that may, in turn, be transformed into promising therapeutics. GEN ...
Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
High-throughput screening (HTS) has come a long way from the early days of robotic plate readers churning through tens of thousands of samples with little more than a binary “hit or miss.” Today, HTS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback